Schroder Investment Management Group’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-640,313
Closed -$7.39M 1639
2020
Q4
$7.39M Buy
640,313
+5,322
+0.8% +$61.4K 0.01% 705
2020
Q3
$6.43M Buy
634,991
+14,127
+2% +$143K 0.01% 682
2020
Q2
$8.16M Sell
620,864
-11,959
-2% -$157K 0.01% 599
2020
Q1
$4.9M Buy
632,823
+22,633
+4% +$175K 0.01% 673
2019
Q4
$12.6M Buy
610,190
+37,382
+7% +$774K 0.02% 593
2019
Q3
$7.97M Buy
572,808
+3,932
+0.7% +$54.7K 0.01% 667
2019
Q2
$7M Buy
568,876
+70,468
+14% +$867K 0.01% 641
2019
Q1
$6.22M Sell
498,408
-57,943
-10% -$723K 0.01% 662
2018
Q4
$6.3K Buy
556,351
+70,621
+15% +$799 0.01% 638
2018
Q3
$9.09M Sell
485,730
-16,612
-3% -$311K 0.02% 617
2018
Q2
$12.7M Sell
502,342
-10,135
-2% -$256K 0.02% 561
2018
Q1
$11.5M Sell
512,477
-4,504
-0.9% -$101K 0.02% 578
2017
Q4
$12.9M Buy
516,981
+89,806
+21% +$2.25M 0.02% 594
2017
Q3
$10.2M Sell
427,175
-82,252
-16% -$1.96M 0.02% 624
2017
Q2
$10.5M Buy
509,427
+115,413
+29% +$2.37M 0.02% 596
2017
Q1
$10.7M Sell
394,014
-196,764
-33% -$5.33M 0.02% 597
2016
Q4
$11.2M Buy
590,778
+259,248
+78% +$4.93M 0.02% 594
2016
Q3
$6.48M Hold
331,530
0.01% 695
2016
Q2
$4.96M Hold
331,530
0.01% 727
2016
Q1
$2.98M Sell
331,530
-138,670
-29% -$1.25M 0.01% 768
2015
Q4
$9.06M Buy
470,200
+81,500
+21% +$1.57M 0.02% 642
2015
Q3
$5.78M Buy
388,700
+23,000
+6% +$342K 0.01% 713
2015
Q2
$7.61M Buy
365,700
+100,800
+38% +$2.1M 0.02% 682
2015
Q1
$5.93M Buy
264,900
+4,900
+2% +$110K 0.01% 735
2014
Q4
$5.25M Buy
+260,000
New +$5.25M 0.01% 778